1 |
Kabanov, A. V., E. V. Batrakova, N. S. Melik-Nubarov, N. A. Fedoseev, T. U. Dorodnich, V. Y. Alakhov, V. P. Chekhonin, I. R. Nazarova, and V. A. Kabanov (1992), A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcantainers for drug targeting from blood in brain, J. Cont. Relaease 22, 141-157
DOI
ScienceOn
|
2 |
Miller, S. C. and M. D. Donovan (1982), Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits, Int. J. Pharm. 12, 147-152
DOI
ScienceOn
|
3 |
Desai, S. D. and J. Blanchard (1998), In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpin, Pharm. Sci. 87, 226-230
DOI
ScienceOn
|
4 |
Urtti, A., M. Juslin, and O. Minalainen (1985), Pilocarpine release from hydroxypropyl-cellulose-polyvinylpyrrolidone matrices, Int. J. Pharm. 25, 165-178
DOI
ScienceOn
|
5 |
Alexandridis, P. and T. A. Hatton (1995), Poly(ethylene oxide)poly( propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling, Colloid & Surfaces A 96, 1-46
DOI
ScienceOn
|
6 |
Alexandridis, P., D. Zhou, A. Khan (1996), Lyotropic Liquid Crystallinity in Amphiphilic Block Copolymers: Temperature Effects on Phase Behavior and Structure for Poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) Copolymers, Langmuir 12, 2690-2700
DOI
ScienceOn
|
7 |
Schmolka, I. R. (1991), Poloxamers in the Pharmaceutical Industry. In Polymers for Controlled Drug Delivery, P. J. Tarcha Eds., p189, CRC Press Boca Raton
|
8 |
Joshi, A., S. Ding, and K. J. Himmelstein (1993), US Patent 5, 252318
|
9 |
Choi, C-S., S.-M. Park, W.-H. Song, C.-M. Lee, K.-Y. Lee, D.-W. Kim, and J.-C. Kim (2003), Release properties of BSA from pectin beads for colonic drug delivery, Kor. J. Biotechnol. 18, 161-164
|
10 |
Katakam, M., L. N. Bell, and A. K. Banga (1995), Effect of surfactants on the physical stability of recombinant human growth hormone, J. Pharm. Sci. 84, 713-716
DOI
ScienceOn
|
11 |
Bhardwaj, R. and J. Blanchard (1996), Using poloxamer 407 controlled-release delivery system for the -MSH analogue melatan-I, J. Pharm. Sci. 85, 915-919
DOI
ScienceOn
|
12 |
Fix, J. A. (1996), Oral controlled release technology for peptides: status and future prospects, Pharm. Res. 13, 1760-1764
DOI
|
13 |
Johnston, T. P., M. A. Punjabi, and C. J. Froelich (1992), Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice, Pharm. Res. 9, 425-434
DOI
|
14 |
Guzman, M., F. F. Garcia, and M. R. Aberturas (1992), Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration, Int. J. Pharm. 80, 119-127
DOI
ScienceOn
|
15 |
Andrianov, A. K. and L. G. payne (1998), Polymeric carriers for oral uptake of microparticulates, Adv. Drug Deliv. Rev. 24, 155-170
|
16 |
Waring, G. O. and R. R. Harris (1979), Double masked evaluation of poloxamer artificial tear in keratoconjunctivitis. In Symposium on Ocular Therapy. Vol. 11, J. H. Leopold and R. P. Burnsm, Eds., p127, Wiley, N.Y.
|
17 |
Schmolka, I. R. (1972), Artificial skin. Preparation and properties of pluronic F-127 gels for the treatment of burns, J. Biomed Mat. Res. 6, 571-582
DOI
|
18 |
Kim, M. S., K. S. Sea, H. Hyun, G. Khang, S. H. Cho, and H. E. Lee (2006), Controlled Release of bovine serum albumin using MPEG-PCL diblock copolymers as implantable protein carriers, J. Appl. Pol. Sci. 102, 1561-1567
DOI
ScienceOn
|
19 |
Ford, J. L. M. H. Rubinstein, F. McCaul, and J. E. Edgar (1987), Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets, Int. J. Pharm. 40, 223-224
DOI
ScienceOn
|